HTX Research, the dedicated research arm of HTX, has released its Q3 2026 outlook report, Liquidity Defines Crypto: A New Crypto Order Under Global Liquidity Repricing. Built around two core themes, ...
Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associated with type 2 diabetes.
Wild greater honeyguide birds in sub-Saharan Africa have learned to recognize specific human vocal calls used by local ...
Objective While guidelines advocate renin-angiotensin system inhibitors (RASi) for renoprotection in lupus nephritis (LN), ...
Fine-scale exogenous attention within the foveola selectively enhances contrast gain at low-to-mid spatial frequencies while increasing response gain across a broad spatial frequency range.